
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Although most pregnant HIVers are prescribed AZT or Viramune to prevent transmission of the virus to their infants, researchers say it may also be possible to use the protease inhibitor Aptivus with the entry inhibitor T-20 when drug resistance is present. A case study in the journal AIDS of a 33-year-old woman resistant to most older anti-HIV drugs showed an Aptivus/T-20-based six-drug salvage regimen helped lower her viral load from above 200,000 copies to just 73 copies, allowing her to avoid transmitting the virus to her infant during delivery.
From our Sponsors
Most Popular
Be sure to follow
Plus on your favorite social platforms!
Facebook
Instagram
Twitter
Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now: https://advocatechannel.com
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video